Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
CA 2458852 A1 · Owner: Petersen, Christian Frimundt · Inventors: Weitz, Jeffrey I.; Johansen, Kristian, Betton; Petersen, Christian Frimundt
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compositions and methods for the treatment of diseases or conditions characterised by excess thrombin generation or activity. In particular, the invention provides conbination compositions comprising low molecular weight heparin (LMWH) and low molecular weight dermatan sulphate (LMWDS). Such compositions are well suited for the treatment of said diseases or conditions, and they exert an effect which is greater than sum of the effects of LMWH and LMWDS if dosed as single agents i.e. the , combination conposition exerts a synergistic effect.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.